Allan Mason, the former accountant to Kerry Packer, during the height of his notoriety, speaks about his best selling book and tips for cutting back tax costs.
For more information about Allan Mason and his book "Tax Secrets of the Rich" please visit: https://allanmason.com.au/
Copyright 2024 – Finance News Network
Source: Finance News Network
12 Aug 2020 - Centuria Capital Group (ASX:CNI) Joint CEO John McBain discusses full year 2020 results, acquisition of Augusta Capital, and guidance for FY21.
Read More17 Apr 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the possibility of falling inflation, immigration and the tight labour market, and the outlook for the equity market.
Read More10 Oct 2023 - Harry Fisher - Project Manager - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Read More10 Oct 2023 - Jon Price - Managing Director - Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
Read More03 Oct 2023 - Alex Hanly, CEO of Lithium Universe Limited (ASX:LU7), provides an update on the company's projects, discussing progress towards developing the Quebec Lithium Processing Hub.
Read More12 Oct 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the FDA fast track designation received in first-line non-small cell lung cancer, the company's new Phase 2 trial in soft tissue sarcoma and the outlook ahead.
Read More28 Aug 2020 - OptiScan Imaging Limited (ASX:OIL) Executive Chairman Darren Lurie provides an update on the company's sales, strategy, and its endomicroscopic imaging technology platform that allows for real-time virtual biopsies via the visualistation of living tissue.
Read More24 Apr 2020 - Telix Pharmaceuticals (ASX:TLX), Chief Business Officer, David Cade talks about its prostate cancer imaging product, diagnostic and therapeutic products, partners and key priorities for 2020.
Read More22 Mar 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on the company's trials.
Read More01 May 2020 - Acorn Capital, Head of Portfolio Implementation and Portfolio manager (Healthcare and Biotechnology sectors) Paul Palumbo looks the microcap sector and the recent market sell off and discusses the outlook for next 6 months and longer term.
Read More
